Coupling between nutrient availability and thyroid hormone activation

Journal of Biological Chemistry

Volumn 290, Issue 51, 2015, Pages 30551-30561

  Lartey, Lattoya J ^a   Werneck De Castro, João Pedro ^b,c   O Sullivan, InSug ^d   Unterman, Terry G ^d   Bianco, Antonio C ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^d UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINS; CHEMICAL ACTIVATION; INSULIN; MAMMALS;

ADENOVIRAL INFECTION; CONSTITUTIVELY ACTIVES; FOOD AVAILABILITY; INSULIN RECEPTORS; NUTRIENT AVAILABILITY; SIGNALING MOLECULES; SPECIFIC INHIBITORS; THYROTROPIN-RELEASING HORMONES;

HORMONES;

2 DEIODINASE; INSULIN; LIOTHYRONINE; MAMMALIAN TARGET OF RAPAMYCIN; MTORC2 PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SOMATOMEDIN C; THYROID HORMONE; THYROXINE; THYROXINE DEIODINASE; TRANSCRIPTION FACTOR FKHR; UNCLASSIFIED DRUG; FORKHEAD TRANSCRIPTION FACTOR; FOXO1 PROTEIN, HUMAN; IODIDE PEROXIDASE; IODOTHYRONINE DEIODINASE TYPE II; MULTIPROTEIN COMPLEX; TARGET OF RAPAMYCIN KINASE; TOR COMPLEX 2;

ACCELERATION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; DIO2 GENE; ENERGY EXPENDITURE; FOOD ANALYSIS; GENE; HORMONE DETERMINATION; HORMONE METABOLISM; HORMONE SYNTHESIS; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; NUTRIENT AVAILABILITY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; BIOSYNTHESIS; DIET RESTRICTION; GENETICS; KNOCKOUT MOUSE; MALE; METABOLISM; SKELETAL MUSCLE;

ANIMALS; FASTING; FORKHEAD BOX PROTEIN O1; FORKHEAD TRANSCRIPTION FACTORS; IODIDE PEROXIDASE; MALE; MICE; MICE, KNOCKOUT; MULTIPROTEIN COMPLEXES; MUSCLE, SKELETAL; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; THYROXINE; TOR SERINE-THREONINE KINASES; TRIIODOTHYRONINE;

EID: 84950326725     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M115.665505     Document Type: Article

References (54)

1. Park, H. K., and Ahima, R. S. (2015) Physiology of leptin: energy homeostasis, neuroendocrine function and metabolism. Metabolism 64, 24-34
2. Burger, A. G., Berger, M., Wimpfheimer, K., and Danforth, E. (1980) Interrelationships between energy metabolism and thyroid hormone metabolism during starvation in the rat. Acta Endocrinol. 93, 322-331
3. O'Brian, J. T., Bybee, D. E., Burman, K. D., Osburne, R. C., Ksiazek, M. R., Wartofsky, L., and Georges, L. P. (1980) Thyroid hormone homeostasis in states of relative caloric deprivation. Metabolism 29, 721-727
4. Schebendach, J. E., Golden, N. H., Jacobson, M. S., Hertz, S., and Shenker, I. R. (1997) The metabolic responses to starvation and refeeding in adolescents with anorexia nervosa. Ann. N.Y. Acad. Sci. 817, 110-119
5. Boelen, A., Wiersinga, W. M., and Fliers, E. (2008) Fasting-induced changes in the hypothalamus-pituitary-thyroid axis. Thyroid 18, 123-129
6. Chan, J. L., Heist, K., DePaoli, A. M., Veldhuis, J. D., and Mantzoros, C. S. (2003) The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men. J. Clin. Invest. 111, 1409-1421
7. Gereben, B., Zavacki, A. M., Ribich, S., Kim, B. W., Huang, S. A., Simonides, W. S., Zeöld, A., and Bianco, A. C. (2008) Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling. Endocr. Rev. 29, 898-938
8. Kinlaw, W. B., Schwartz, H. L., and Oppenheimer, J. H. (1985) Decreased serum triiodothyronine in starving rats is due primarily to diminished thyroidal secretion of thyroxine. J. Clin. Invest. 75, 1238-1241
9. Vella, K. R., Ramadoss, P., Lam, F. S., Harris, J. C., Ye, F. D., Same, P. D., O'Neill, N. F., Maratos-Flier, E., and Hollenberg, A. N. (2011) NPY and MC4R signaling regulate thyroid hormone levels during fasting through both central and peripheral pathways. Cell Metab. 14, 780-790
10. Galton, V. A., Hernandez, A., and St Germain, D. L. (2014) The 5′-deiodinases are not essential for the fasting-induced decrease in circulating thyroid hormone levels in male mice: possible roles for the type 3 deiodinase and tissue sequestration of hormone. Endocrinology 155, 3172-3181
11. Balsam, A., and Ingbar, S. H. (1978) The influence of fasting, diabetes, and several pharmacological agents on the pathways of thyroxine metabolism in rat liver. J. Clin. Invest. 62, 415-424
12. Zavacki, A. M., Ying, H., Christoffolete, M. A., Aerts, G., So, E., Harney, J. W., Cheng, S. Y., Larsen, P. R., and Bianco, A. C. (2005) Type 1 iodothyronine deiodinase is a sensitive marker of peripheral thyroid status in the mouse. Endocrinology 146, 1568-1575
13. Bianco, A. C. (2011) Minireview: cracking the metabolic code for thyroid hormone signaling. Endocrinology 152, 3306-3311
14. Gereben, B., and Salvatore, D. (2005) Pretranslational regulation of type 2 deiodinase. Thyroid 15, 855-864
15. Dentice, M., Marsili, A., Ambrosio, R., Guardiola, O., Sibilio, A., Paik, J. H., Minchiotti, G., DePinho, R. A., Fenzi, G., Larsen, P. R., and Salvatore, D. (2010) The FoxO3/type 2 deiodinase pathway is required for normal mouse myogenesis and muscle regeneration. J. Clin. Invest. 120, 4021-4030
16. Arrojo E Drigo, R., Fonseca, T. L., Castillo, M., Salathe, M., Simovic, G., Mohácsik, P., Gereben, B., and Bianco, A. C. (2011) Endoplasmic reticulum stress decreases intracellular thyroid hormone activation via an eIF2a-mediated decrease in type 2 deiodinase synthesis. Mol. Endocrinol. 25, 2065-2075
17. Sagar, G. D., Gereben, B., Callebaut, I., Mornon, J. P., Zeöld, A., da Silva, W. S., Luongo, C., Dentice, M., Tente, S. M., Freitas, B. C., Harney, J. W., Zavacki, A. M., and Bianco, A. C. (2007) Ubiquitination-induced conformational change within the deiodinase dimer is a switch regulating enzyme activity. Mol. Cell. Biol. 27, 4774-4783
18. Martinez-deMena, R., and Obregón, M. J. (2005) Insulin increases the adrenergic stimulation of 5′ deiodinase activity and mRNA expression in rat brown adipocytes; role of MAPK and PI3K. J. Mol. Endocrinol. 34, 139-151
19. Mills, I., Barge, R. M., Silva, J. E., and Larsen, P. R. (1987) Insulin stimulation of iodothyronine 5′-deiodinase in rat brown adipocytes. Biochem. Biophys. Res. Commun. 143, 81-86
20. Laplante, M., and Sabatini, D. M. (2009)mTORsignaling at a glance. J. Cell Sci. 122, 3589-3594
21. Hoeffer, C. A., and Klann, E. (2010) mTOR signaling: at the crossroads of plasticity, memory and disease. Trends Neurosci. 33, 67-75
22. Frost, R. A., and Lang, C. H. (2011) mTor signaling in skeletal muscle during sepsis and inflammation: where does it all go wrong? Physiology 26, 83-96
23. Thoreen, C. C., Chantranupong, L., Keys, H. R., Wang, T., Gray, N. S., and Sabatini, D. M. (2012) A unifying model for mTORC1-mediated regulation of mRNA translation. Nature 485, 109-113
24. Düvel, K., Yecies, J. L., Menon, S., Raman, P., Lipovsky, A. I., Souza, A. L., Triantafellow, E., Ma, Q., Gorski, R., Cleaver, S., Vander Heiden, M. G., MacKeigan, J. P., Finan, P. M., Clish, C. B., Murphy, L. O., and Manning, B. D. (2010) Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Mol. Cell 39, 171-183
25. Su, B., and Jacinto, E. (2011) Mammalian TOR signaling to the AGC kinases. Crit. Rev. Biochem. Mol. Biol. 46, 527-547
26. Ma, X. M., and Blenis, J. (2009) Molecular mechanisms of mTOR-mediated translational control. Nat. Rev. Mol. Cell Biol. 10, 307-318
27. Grozovsky, R., Ribich, S., Rosene, M. L., Mulcahey, M. A., Huang, S. A., Patti, M. E., Bianco, A. C., and Kim, B. W. (2009) Type 2 deiodinase expression is induced by peroxisomal proliferator-activated receptor-β agonists in skeletal myocytes. Endocrinology 150, 1976-1983
28. Mills, I., Raasmaja, A., Moolten, N., Lemack, G., Silva, J. E., and Larsen, P. R. (1989) Effect of thyroid status on catecholamine stimulation of thyroxine 5′-deiodinase in brown adipocytes. Am. J. Physiol. 256, E74-E79
29. Bianco, A. C., Anderson, G., Forrest, D., Galton, V. A., Gereben, B., Kim, B. W., Kopp, P. A., Liao, X. H., Obregon, M. J., Peeters, R. P., Refetoff, S., Sharlin, D. S., Simonides, W. S., Weiss, R. E., Williams, G. R., American Thyroid Association Task Force on Approaches and Strategies to Investigate Thyroid Hormone Economy and Action (2014) American thyroid association guide to investigating thyroid hormone economy and action in rodent and cell models. Thyroid 24, 88-168
30. Curcio, C., Baqui, M. M., Salvatore, D., Rihn, B. H., Mohr, S., Harney, J. W., Larsen, P. R., and Bianco, A. C. (2001) The human type 2 iodothyronine deiodinase is a selenoprotein highly expressed in a mesothelioma cell line. J. Biol. Chem. 276, 30183-30187
31. da-Silva, W. S., Harney, J. W., Kim, B. W., Li, J., Bianco, S. D., Crescenzi, A., Christoffolete, M. A., Huang, S. A., and Bianco, A. C. (2007) The small polyphenolic molecule kaempferol increases cellular energy expenditure and thyroid hormone activation. Diabetes 56, 767-776
32. Zhang, W., Patil, S., Chauhan, B., Guo, S., Powell, D. R., Le, J., Klotsas, A., Matika, R., Xiao, X., Franks, R., Heidenreich, K. A., Sajan, M. P., Farese, R. V., Stolz, D. B., Tso, P., Koo, S. H., Montminy, M., and Unterman, T. G. (2006) FoxO1 regulates multiple metabolic pathways in the liver: effects on gluconeogenic, glycolytic, and lipogenic gene expression. J. Biol. Chem. 281, 10105-10117
33. O-Sullivan, I., Zhang, W., Wasserman, D. H., Liew, C. W., Liu, J., Paik, J., DePinho, R. A., Stolz, D. B., Kahn, C. R., Schwartz, M. W., and Unterman, T. G. (2015) FoxO1 integrates direct and indirect effects of insulin on hepatic glucose production and glucose utilization. Nat. Commun. 6, 7079
34. Ferrara, A. M., Liao, X. H., Gil-Ibáñez, P., Marcinkowski, T., Bernal, J., Weiss, R. E., Dumitrescu, A. M., and Refetoff, S. (2013) Changes in thyroid status during perinatal development of MCT8-deficient male mice. Endocrinology 154, 2533-2541
35. Arrojo E Drigo, R., and Bianco, A. C. (2011) Type 2 deiodinase at the crossroads of thyroid hormone action. Int. J. Biochem. Cell Biol. 43, 1432-1441
36. Levy, D. S., Kahana, J. A., and Kumar, R. (2009) AKT inhibitor, GSK690693, induces growth inhibition and apoptosis in acute lymphoblastic leukemia cell lines. Blood 113, 1723-1729
37. Carol, H., Morton, C. L., Gorlick, R., Kolb, E. A., Keir, S. T., Reynolds, C. P., Kang, M. H., Maris, J. M., Billups, C., Smith, M. A., Houghton, P. J., and Lock, R. B. (2010) Initial testing (stage 1) of the Akt inhibitor GSK690693 by the pediatric preclinical testing program. Pediatr. Blood Cancer 55, 1329-1337
38. Feldman, M. E., Apsel, B., Uotila, A., Loewith, R., Knight, Z. A., Ruggero, D., and Shokat, K. M. (2009) Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2. PLoS Biol. 7, e38
39. Guertin, D. A., and Sabatini, D. M. (2009) The pharmacology of mTOR inhibition. Sci. Signal. 2, pe24
40. Dowling, R. J., Topisirovic, I., Fonseca, B. D., and Sonenberg, N. (2010) Dissecting the role of mTOR: lessons from mTOR inhibitors. Biochim. Biophys. Acta 1804, 433-439
41. Oh, W. J., and Jacinto, E. (2011)mTORcomplex 2 signaling and functions. Cell Cycle 10, 2305-2316
42. Nagashima, T., Shigematsu, N., Maruki, R., Urano, Y., Tanaka, H., Shimaya, A., Shimokawa, T., and Shibasaki, M. (2010) Discovery of novel forkhead box O1 inhibitors for treating type 2 diabetes: improvement of fasting glycemia in diabetic db/db mice. Mol. Pharmacol. 78, 961-970
43. Heemstra, K. A., Soeters, M. R., Fliers, E., Serlie, M. J., Burggraaf, J., van Doorn, M. B., van der Klaauw, A. A., Romijn, J. A., Smit, J. W., Corssmit, E. P., and Visser, T. J. (2009) Type 2 iodothyronine deiodinase in skeletal muscle: effects of hypothyroidism and fasting. J. Clin. Endocrinol. Metab. 94, 2144-2150
44. Brent, G. A. (2012) Mechanisms of thyroid hormone action. J. Clin. Invest. 122, 3035-3043
45. Hall, J. A., Ribich, S., Christoffolete, M. A., Simovic, G., Correa-Medina, M., Patti, M. E., and Bianco, A. C. (2010) Absence of thyroid hormone activation during development underlies a permanent defect in adaptive thermogenesis. Endocrinology 151, 4573-4582
46. Simonides, W. S., and van Hardeveld, C. (2008) Thyroid hormone as a determinant of metabolic and contractile phenotype of skeletal muscle. Thyroid 18, 205-216
47. Dentice, M., Ambrosio, R., Damiano, V., Sibilio, A., Luongo, C., Guardiola, O., Yennek, S., Zordan, P., Minchiotti, G., Colao, A., Marsili, A., Brunelli, S., Del Vecchio, L., Larsen, P. R., Tajbakhsh, S., and Salvatore, D. (2014) Intracellular inactivation of thyroid hormone is a survival mechanism for muscle stem cell proliferation and lineage progression. Cell Metab. 20, 1038-1048
48. Fonseca, T. L., Werneck-De-Castro, J. P., Castillo, M., Bocco, B. M., Fernandes, G. W., McAninch, E. A., Ignacio, D. L., Moises, C. C., Ferreira, A. R., Gereben, B., and Bianco, A. C. (2014) Tissue-specific inactivation of type 2 deiodinase reveals multilevel control of fatty acid oxidation by thyroid hormone in the mouse. Diabetes 63, 1594-1604
49. Werneck-de-Castro, J. P., Fonseca, T. L., Ignacio, D. L., Fernandes, G. W., Andrade-Feraud, C. M., Lartey, L. J., Ribeiro, M. B., Ribeiro, M. O., Gereben, B., and Bianco, A. C. (2015) Thyroid hormone signaling in male mouse skeletal muscle is largely independent of D2 in myocytes. Endocrinology 156, 3842-3852
50. Hay, N., and Sonenberg, N. (2004) Upstream and downstream of mTOR. Genes Dev. 18, 1926-1945
51. Kim, S. G., Buel, G. R., and Blenis, J. (2013) Nutrient regulation of the mTOR complex 1 signaling pathway. Mol. Cells 35, 463-473
52. Nakae, J., Kitamura, T., Kitamura, Y., Biggs, W. H., 3rd, Arden, K. C., and Accili, D. (2003) The forkhead transcription factor Foxo1 regulates adipocyte differentiation. Dev. Cell 4, 119-129
53. Barthel, A., Schmoll, D., and Unterman, T. G. (2005) FoxO proteins in insulin action and metabolism. Trends Endocrinol. Metab. 16, 183-189
54. Matsumoto, M., Han, S., Kitamura, T., and Accili, D. (2006) Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism. J. Clin. Invest. 116, 2464-2472